Back to Caligan Partners LP
Q3 2026 13F filing
Updated 6 days ago26 disclosed positions worth $1.6B
Portfolio value
$1.6B
Total holdings
26
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-16
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R REVOLUTION MEDICINES INC | $402.7M | 1.96M | 24.64% | — |
| 2 | L LIQUIDIA CORPORATION | $245.7M | 8.12M | 15.03% | — |
| 3 | A ABIVAX SA | $154.3M | 1.56M | 9.44% | — |
| 4 | P VAXCYTE INC | $124.5M | 2.19M | 7.62% | — |
| 5 | E EXELIXIS INC | $90.7M | 1.55M | 5.55% | — |
| 6 | T TANGO THERAPEUTICS INC | $62.4M | 2.50M | 3.82% | — |
| 7 | A ADMA BIOLOGICS INC | $58.9M | 5.88M | 3.61% | — |
| 8 | I IMMUNOCORE HLDGS PLC | $50.6M | 1.67M | 3.10% | — |
| 9 | A AVALO THERAPEUTICS INC | $50.1M | 3.27M | 3.07% | — |
| 10 | L LB PHARMACEUTICALS INC | $49.6M | 1.51M | 3.04% | — |
| 11 | V VIRIDIAN THERAPEUTICS INC | $45.2M | 2.19M | 2.76% | — |
| 12 | V VOR BIOPHARMA INC | $36.7M | 1.93M | 2.25% | — |
| 13 | I INVENTIVA SA | $33.9M | 9.19M | 2.07% | — |
| 14 | I OPUS GENETICS INC | $28.9M | 5.96M | 1.77% | — |
| 15 | A AURA BIOSCIENCES INC | $28.8M | 4.59M | 1.76% | — |
| 16 | A ANIKA THERAPEUTICS INC | $28.2M | 1.44M | 1.73% | — |
| 17 | S SAB BIOTHERAPEUTICS INC | $27.7M | 8.74M | 1.69% | — |
| 18 | S SAGIMET BIOSCIENCES INC | $27.6M | 2.79M | 1.69% | — |
| 19 | F FAETH THERAPEUTICS INC | $26.5M | 890.2K | 1.62% | — |
| 20 | T TYRA BIOSCIENCES INC | $19.9M | 910.7K | 1.22% | — |
| 21 | O OBSIDIAN THERAPEUTICS INC | $12.2M | 886.3K | 0.74% | — |
| 22 | E EUPRAXIA PHARMACEUTICALS INC | $10.6M | 1.16M | 0.65% | — |
| 23 | A ARTIVA BIOTHERAPEUTICS INC | $10.5M | 1.48M | 0.65% | — |
| 24 | V VERRICA PHARMACEUTICALS INC | $4.4M | 923.9K | 0.27% | — |
| 25 | ? N/A TCGX ACQUISITION CORP | $2.5M | 200.0K | 0.15% | — |
| 26 | ? N/A CELLECTAR BIOSCIENCES INC | $865K | 470.0K | 0.05% | — |